Effects of structurally different lipid emulsions on human neutrophil migration.
OBJECTIVE
To test the hypothesis that structurally different lipid emulsions have distinct immunomodulatory properties, we analysed neutrophil migration in the presence of various lipid emulsions.


METHODS
Neutrophils of 8 volunteers were pre-incubated in medium or physiological 2.5 mM emulsions containing long-chain (LCT), medium-chain (MCT), mixed LCT/MCT, alpha -tocopherol-enriched LCT/MCT (LCT/MCT-E) or structured triglycerides (SL). Thereafter, the cells were put on top of 3 microm-pore-sized cell culture filters and incubated for one hour in the presence or absence of a chemo-attractant. Neutrophil migration was measured as the percentage of cells that had passed the filter in the presence (chemotaxis) or absence (random migration) of a chemotactic factor.


RESULTS
Compared to lipid-free incubation (19+/-1%) random neutrophil migration significantly decreased with LCT/MCT (11+/-2%), LCT/MCT-E (12+/-2) and MCT (5+/-2%), while LCT (18+/-3%) and SL (20+/-1%) had no effect. N-formyl-methionyl-leucyl-phenylalanine- (fMLP, 10(-8)M) or zymosan-activated-serum-induced (ZAS, 10%) filter passage under lipid-free conditions amounted to 61+/-14% and 70+/-13%, respectively. These values decreased with LCT/MCT to 11+/-9% and 15+/-7%; with LCT/MCT-E to 18+/-10% and 28+/-12%; with SL to 39+/-18% and 57+/-14%, and with MCT to 5+/-2% and 10+/-6%, (all P<0.01), while LCT had no effect. Compared to LCT/MCT, the alpha -tocopherol-enriched formulation significantly increased ZAS- and fMLP-induced chemotaxis. fMLP-induced chemotaxis decreased in direct proportion to LCT/MCT triglyceride concentration.


CONCLUSIONS
Human neutrophil migration is distinctively inhibited by structurally different lipid emulsions, depending on triglyceride chain-length and concentration as well as alpha -tocopherol content.
Wanten
G J
GJ
Department of Gastroenterology, University Hospital, Nijmegen, The Netherlands.
Roos
D
D
Naber
A H
AH
D000328:Adult; D002634:Chemotaxis, Leukocyte / Q000187:drug effects*; D005217:Fat Emulsions, Intravenous / Q000737:chemistry* / Q000494:pharmacology; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D008055:Lipids / Q000737:chemistry / Q000494:pharmacology*; D008297:Male; D008875:Middle Aged; D009504:Neutrophils / Q000187:drug effects* / Q000502:physiology; D014280:Triglycerides / Q000737:chemistry / Q000494:pharmacology; D014810:Vitamin E / Q000494:pharmacology*
D005217:Fat Emulsions, Intravenous; D008055:Lipids; D014280:Triglycerides; D014810:Vitamin E